Logo image of MNTK

MONTAUK RENEWABLES INC (MNTK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MNTK - US61218C1036 - Common Stock

1.47 USD
+0.05 (+3.52%)
Last: 1/15/2026, 12:50:19 PM
Fundamental Rating

2

MNTK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. MNTK has a bad profitability rating. Also its financial health evaluation is rather negative. MNTK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year MNTK has reported negative net income.
  • In the past year MNTK had a positive cash flow from operations.
  • Of the past 5 years MNTK 4 years were profitable.
  • Each year in the past 5 years MNTK had a positive operating cash flow.
MNTK Yearly Net Income VS EBIT VS OCF VS FCFMNTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.40%, MNTK is doing worse than 70.00% of the companies in the same industry.
  • With a Return On Equity value of -3.53%, MNTK perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -2.4%
ROE -3.53%
ROIC N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)N/A
ROIC(5y)N/A
MNTK Yearly ROA, ROE, ROICMNTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • MNTK's Profit Margin has been stable in the last couple of years.
  • MNTK's Operating Margin has declined in the last couple of years.
  • The Gross Margin of MNTK (34.69%) is worse than 60.00% of its industry peers.
  • In the last couple of years the Gross Margin of MNTK has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for MNTK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.69%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
MNTK Yearly Profit, Operating, Gross MarginsMNTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

2

2. Health

2.1 Basic Checks

  • MNTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MNTK has more shares outstanding
  • Compared to 5 years ago, MNTK has more shares outstanding
  • MNTK has a better debt/assets ratio than last year.
MNTK Yearly Shares OutstandingMNTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
MNTK Yearly Total Debt VS Total AssetsMNTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • MNTK has an Altman-Z score of 1.46. This is a bad value and indicates that MNTK is not financially healthy and even has some risk of bankruptcy.
  • MNTK's Altman-Z score of 1.46 is fine compared to the rest of the industry. MNTK outperforms 70.00% of its industry peers.
  • A Debt/Equity ratio of 0.21 indicates that MNTK is not too dependend on debt financing.
  • MNTK's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. MNTK outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 1.46
ROIC/WACCN/A
WACC8.14%
MNTK Yearly LT Debt VS Equity VS FCFMNTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 0.33 indicates that MNTK may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.33, MNTK is doing worse than 90.00% of the companies in the same industry.
  • MNTK has a Quick Ratio of 0.33. This is a bad value and indicates that MNTK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of MNTK (0.33) is worse than 85.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
MNTK Yearly Current Assets VS Current LiabilitesMNTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

  • MNTK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -140.00%.
  • Measured over the past years, MNTK shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.33% on average per year.
  • Looking at the last year, MNTK shows a very negative growth in Revenue. The Revenue has decreased by -17.54% in the last year.
  • The Revenue has been growing by 10.70% on average over the past years. This is quite good.
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-17.54%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-31.34%

3.2 Future

  • MNTK is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.34% yearly.
  • MNTK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.09% yearly.
EPS Next Y-117%
EPS Next 2Y-41.69%
EPS Next 3Y18.01%
EPS Next 5Y6.34%
Revenue Next Year-13.63%
Revenue Next 2Y-0.2%
Revenue Next 3Y5.09%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNTK Yearly Revenue VS EstimatesMNTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
MNTK Yearly EPS VS EstimatesMNTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 0.2 0.3

1

4. Valuation

4.1 Price/Earnings Ratio

  • MNTK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 72.06, which means the current valuation is very expensive for MNTK.
  • MNTK's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, MNTK is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 72.06
MNTK Price Earnings VS Forward Price EarningsMNTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MNTK is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.28
MNTK Per share dataMNTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • MNTK's earnings are expected to grow with 18.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.69%
EPS Next 3Y18.01%

0

5. Dividend

5.1 Amount

  • MNTK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MONTAUK RENEWABLES INC

NASDAQ:MNTK (1/15/2026, 12:50:19 PM)

1.47

+0.05 (+3.52%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-05
Earnings (Next)03-10
Inst Owners16.86%
Inst Owner Change0.02%
Ins Owners53.73%
Ins Owner Change0%
Market Cap210.45M
Revenue(TTM)160.68M
Net Income(TTM)-9.20M
Analysts74.55
Price Target3.23 (119.73%)
Short Float %3.05%
Short Ratio8.6
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-116.81%
Min EPS beat(2)-413.72%
Max EPS beat(2)180.11%
EPS beat(4)1
Avg EPS beat(4)-139.36%
Min EPS beat(4)-413.72%
Max EPS beat(4)180.11%
EPS beat(8)3
Avg EPS beat(8)-76.06%
EPS beat(12)3
Avg EPS beat(12)-77.59%
EPS beat(16)3
Avg EPS beat(16)-69.3%
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-0.71%
Max Revenue beat(2)1.62%
Revenue beat(4)1
Avg Revenue beat(4)-13.09%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)1.62%
Revenue beat(8)2
Avg Revenue beat(8)-11.35%
Revenue beat(12)3
Avg Revenue beat(12)-12.63%
Revenue beat(16)5
Avg Revenue beat(16)-7.61%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)30%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)42.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 72.06
P/S 1.31
P/FCF N/A
P/OCF 6.85
P/B 0.81
P/tB 0.87
EV/EBITDA 11.28
EPS(TTM)-0.06
EYN/A
EPS(NY)0.02
Fwd EY1.39%
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.21
OCFY14.6%
SpS1.12
BVpS1.82
TBVpS1.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.4%
ROE -3.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.69%
FCFM N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)9.89%
ROCE(5y)6.65%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
F-Score3
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 2.35
Cap/Depr 302.02%
Cap/Sales 52.34%
Interest Coverage N/A
Cash Conversion 131.56%
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z 1.46
F-Score3
WACC8.14%
ROIC/WACCN/A
Cap/Depr(3y)223.62%
Cap/Depr(5y)158.87%
Cap/Sales(3y)27.46%
Cap/Sales(5y)21.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-66.67%
EPS Next Y-117%
EPS Next 2Y-41.69%
EPS Next 3Y18.01%
EPS Next 5Y6.34%
Revenue 1Y (TTM)-17.54%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-31.34%
Revenue Next Year-13.63%
Revenue Next 2Y-0.2%
Revenue Next 3Y5.09%
Revenue Next 5YN/A
EBIT growth 1Y-112.86%
EBIT growth 3Y53.64%
EBIT growth 5Y5.49%
EBIT Next Year-1.45%
EBIT Next 3Y22.38%
EBIT Next 5Y5.16%
FCF growth 1Y-278.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.8%
OCF growth 3Y0.71%
OCF growth 5Y9.49%

MONTAUK RENEWABLES INC / MNTK FAQ

What is the ChartMill fundamental rating of MONTAUK RENEWABLES INC (MNTK) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MNTK.


Can you provide the valuation status for MONTAUK RENEWABLES INC?

ChartMill assigns a valuation rating of 1 / 10 to MONTAUK RENEWABLES INC (MNTK). This can be considered as Overvalued.


How profitable is MONTAUK RENEWABLES INC (MNTK) stock?

MONTAUK RENEWABLES INC (MNTK) has a profitability rating of 2 / 10.


What is the expected EPS growth for MONTAUK RENEWABLES INC (MNTK) stock?

The Earnings per Share (EPS) of MONTAUK RENEWABLES INC (MNTK) is expected to decline by -117% in the next year.